THE PEER-REVIEWED FORUM FOR EVIDENCE IN BENEFIT DESIGN ™ FEBRUARY/MARCH 2009
VOLUME 2, NUMBER 2
REGULATORY
What Changes Can Your Health Plan Expect from the New Administration? Interview with Dan Mendelson Stakeholder Perspective by Joseph R. Antos, PhD BUSINESS
Patient Cost-Sharing on the Rise: Results from the Benefit Design Index ™
Melinda C. Haren, RN; Kirk McConnell Stakeholder Perspective by David Williams
Employer-Based Health Initiative: Impact on Employees’ Cardiovascular Outcomes Claiborne E. Reeder, RPh, PhD; Christine H. Divers, PhD, MS; Del Deem; Becky J. Cherney; Gaye Fortner, RN, BSN, MSN; Louise Y. Probst Stakeholder Perspective by Charles E. Collins, Jr, MS, MBA CLINICAL
Methicillin-Resistant Staphylococcus aureus : A Growing Risk in the Hospital and in the Community Jose L. Raygada, MD; Donald P. Levine, MD Stakeholder Perspective by Dennis M. Perrotta, PhD, CIC DEPARTMENTS ◆ FDA Watch Commentary by Nirav R. Shah, MD, MPH Commentary by F. Randy Vogenberg, RPh, PhD ◆ Generic Drug Trends
©2009 Engage Healthcare Communications, LLC www.AHDBonline.com